Your browser doesn't support javascript.
loading
Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.
Hänsch, Lena; Peipp, Matthias; Mastall, Maximilian; Villars, Danielle; Myburgh, Renier; Silginer, Manuela; Weiss, Tobias; Gramatzki, Dorothee; Vasella, Flavio; Manz, Markus G; Weller, Michael; Roth, Patrick.
Afiliación
  • Hänsch L; Department of Neurology and Brain Tumor Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Peipp M; Division of Antibody-Based Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Mastall M; Division of Antibody-based Immunotherapy, Christian-Albrechts-University, Kiel, Germany.
  • Villars D; Department of Neurology and Brain Tumor Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Myburgh R; Department of Neurology and Brain Tumor Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Silginer M; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Weiss T; Department of Neurology and Brain Tumor Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Gramatzki D; Department of Neurology and Brain Tumor Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Vasella F; Department of Neurology and Brain Tumor Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Manz MG; Department of Neurology and Brain Tumor Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Weller M; Department of Neurosurgery, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Roth P; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Neuro Oncol ; 25(11): 2001-2014, 2023 11 02.
Article en En | MEDLINE | ID: mdl-37335916

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glioblastoma / Receptores Quiméricos de Antígenos / Glioma Límite: Animals / Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glioblastoma / Receptores Quiméricos de Antígenos / Glioma Límite: Animals / Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Suiza